United Kingdom Needle Free Injections Market Outlook to 2023

GDMECC2511DB
Pages: 26
July 2017
Total Views:1103
Region : Europe
GlobalData
Market Research Report

Select a License

Single User License

USD 4995

Site License

USD 9990

Corporate User License

USD 14985

Details
Table Of Content
Licence Rights
Section Purchase
Products and Companies

Details

United Kingdom Needle Free Injections Market Outlook to 2023

Summary

GlobalData's new report, "United Kingdom Needle Free Injections Market Outlook to 2023", provides key market data on the United Kingdom Needle Free Injections market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Needle Free Injections.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Needle Free Injections.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the United Kingdom Needle Free Injections market.

Key players covered include INJEX-Equidyne Systems, Bioject Medical Technologies Inc and Antares Pharma Inc.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 Needle Free Injections Market Segmentation 4

2.3 Definitions of Markets Covered in the Report 5

3 Needle Free Injections Market, United Kingdom 6

3.1 Needle Free Injections Market, United Kingdom, Revenue ($m), 2009-2016 6

3.2 Needle Free Injections Market, United Kingdom, Revenue ($m), 2016-2023 7

3.3 Needle Free Injections Market, United Kingdom, Volume (Units), 2009-2016 8

3.4 Needle Free Injections Market, United Kingdom, Volume (Units), 2016-2023 9

3.5 Needle Free Injections Market, United Kingdom, Average Price ($), 2009-2023 10

3.6 Needle Free Injections Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 11

3.7 Needle Free Injections Market, United Kingdom, Company Share by Revenue ($m), 2016 12

4 Overview of Key Companies in United Kingdom, Needle Free Injections Market 14

4.1 INJEX-Equidyne Systems 14

4.1.1 Company Overview 14

4.2 Bioject Medical Technologies Inc 14

4.2.1 Company Overview 14

4.3 Antares Pharma Inc 14

4.3.1 Company Overview 14

4.4 PharmaJet Inc 14

4.4.1 Company Overview 14

5 Needle Free Injections Market Pipeline Products 15

6 Financial Deals Landscape 16

6.1 Venture Financing 16

6.1.1 Glide Technologies Raises USD4 Million in Venture Financing 16

6.1.2 Glide Pharma Raises USD4 Million in Venture Financing 17

7 Recent Developments 18

7.1 Corporate Communications 18

7.1.1 Dec 14, 2016: Consort Medical: Directorate Change 18

7.1.2 Nov 25, 2016: Consort Medical: CFO Appointment 18

7.1.3 Nov 14, 2016: Olympus VISERA 4K UHD Receives "Excellence in Surgical Products Awards," Minimally Invasive Surgical Product Category 18

7.1.4 Aug 17, 2016: Consort Medical Announces Directorate Change 19

7.2 Financial Announcements 20

7.2.1 Jun 15, 2017: Consort Medical: Full year results 20

7.2.2 Dec 06, 2016: Consort Medical Reports Interim Results Results For The Six Months Ended 31 October 2016 20

8 Appendix 22

8.1 Research Methodology 23

8.1.1 Coverage 23

8.1.2 Secondary Research 23

8.1.3 Primary Research 24

8.1.4 Company Share Analysis 24

8.1.5 Distribution Share Analysis 24

8.1.6 Benchmarking 25

8.2 GlobalData Consulting 25

8.3 Contact Us 26

8.4 Disclaimer 26

List Of Figure

1.2 List of Figures

Figure 1: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 6

Figure 2: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 7

Figure 3: Needle Free Injections Market, United Kingdom, Volume (Units), Historic, 2009-2016 8

Figure 4: Needle Free Injections Market, United Kingdom, Volume (Units), Forecast, 2016-2023 9

Figure 5: Needle Free Injections Market, United Kingdom, Company Share (%) 2016 12

List Of Table

1.1 List of Tables

Table 1: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 6

Table 2: Needle Free Injections Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 7

Table 3: Needle Free Injections Market, United Kingdom, Volume (Units), Historic, 2009-2016 8

Table 4: Needle Free Injections Market, United Kingdom, Volume (Units), Forecast, 2016-2023 9

Table 5: Needle Free Injections Market, United Kingdom, Average Price ($), Historic, 2009-2016 10

Table 6: Needle Free Injections Market, United Kingdom, Average Price ($), Forecast, 2016-2023 10

Table 7: Needle Free Injections Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 11

Table 8: Needle Free Injections Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 13

Table 9: Needle Free Injections Market Pipeline Products 15

Table 10: Glide Technologies Raises USD4 Million in Venture Financing 16

Table 11: Glide Pharma Raises USD4 Million in Venture Financing 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

Companies

INJEX-Equidyne Systems

Bioject Medical Technologies Inc

Antares Pharma Inc

PharmaJet Inc